| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 43,215 | 43,305 | 24.04. | |
| 43,060 | 43,495 | 24.04. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 170,00 | 8 | |||
| 135,00 | 57 | |||
| 60,00 | 15 | |||
| 52,60 | 100 | |||
| 52,20 | 500 | |||
| 51,76 | 50 | |||
| 44,255 | 20 | |||
| 44,240 | 20 | |||
| 44,230 | 50 | |||
| 43,985 | 172 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 172 | 43,820 | |||
| 111 | 43,805 | |||
| 111 | 43,705 | |||
| 111 | 43,690 | |||
| 20 | 43,590 | |||
| 100 | 41,000 | |||
| 37 | 36,000 | |||
| 50 | 35,000 | |||
| 55 | 26,000 | |||
| 120 | 20,800 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 887 | 1,118 | 992 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:46 | 43,630 | 1 |
| 17:27:42 | 43,685 | 19 |
| 17:27:42 | 43,685 | 23 |
| 17:23:31 | 43,665 | 73 |
| 17:23:31 | 43,700 | 142 |
| 17:08:37 | 43,560 | 122 |
| 16:45:42 | 44,200 | 49 |
| 16:44:22 | 44,210 | 100 |
| 16:43:48 | 44,180 | 182 |
| 16:43:48 | 44,185 | 28 |
| 16:43:01 | 44,385 | 90 |
| 16:42:01 | 44,320 | 70 |
| 16:41:25 | 44,240 | 182 |
| 16:41:25 | 44,245 | 126 |
| 16:40:30 | 44,475 | 40 |
| 16:40:15 | 44,455 | 90 |
| 16:39:20 | 44,355 | 144 |
| 16:39:20 | 44,435 | 3 |
| 16:39:06 | 44,520 | 348 |
| 16:39:06 | 44,515 | 127 |
| Tagesumsatz Xetra | -3,010 -6,45 % | 8.080 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | CureVac sues Moderna for patent infringement over COVID-19 vaccines | 4 | Reuters | ||
| Fr | CureVac sues Moderna over mRNA vaccine patents | 4 | Investing.com | ||
| Fr | CureVac verklagt Moderna wegen Patentverletzung bei mRNA-Impfstoffen | 6 | Investing.com Deutsch | ||
| Mi | Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial | 23 | BioPharma Dive | ||
| MODERNA Aktie jetzt für 0€ handeln | |||||
| Mi | Moderna starts late-stage trial for bird flu vaccine | 9 | Seeking Alpha |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Fr | dpa-AFX-Überblick: UNTERNEHMEN vom 24.04.2026 - 15.15 Uhr | dpa-AFX | ROUNDUP: SAP erwartet schwächeres Wachstum - Cloudsoftware bleibt Motor WALLDORF - Europas größter Softwarehersteller SAP rechnet trotz seiner gefragten Cloudsoftware in diesem Jahr vorerst mit einem... ► Artikel lesen | |
| Fr | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2026.ISIN NameCA46658Y1034 J2... ► Artikel lesen | |
| Fr | Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | AFX News | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen | |
| Fr | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 00:38 | Defence Therapeutics Inc.: Defence Therapeutics Announces Grant of Restricted Stock Units | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision... ► Artikel lesen |